Paper36975019
Blood pressure control for diabetic retinopathy.
Do DV and 5 others. Cochrane Database Syst Rev, 2023. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Blood pressure control for diabetic retinopathy. Papers, record 36975019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36975019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Systematic Review, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Retinopathy | Major topic |
| Macular Edema | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hypertension | Major topic |
| Humans | |
| Blood Pressure | |
| Antihypertensive Agents | |
| Randomized Controlled Trials as Topic |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 EY020522 | NEI NIH HHS | United States | U01EY020522 | PubMed and NIH |
Source NIH RePORTER
Trials5
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00134160 | OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT00185159 | Olmesartan Medoxomil in Diabetes Mellitus | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT00237549 | The ADDITION Study. Intensive Treatment in People With Screen Detected Diabetes in Primary Care. | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT00320008 | Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT00542178 | Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) | Derived from the trial | Yes | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Update of | 25637717 | Blood pressure control for diabetic retinopathy. | https://conductscience.org/library/papers/25637717 | PubMed |
| Comment in | 39172669 | Blood Pressure Control for Patients With Diabetic Retinopathy. | https://conductscience.org/library/papers/39172669 | PubMed |
References188
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8960842 | Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control. | Diabetologia | 1996 | https://conductscience.org/library/papers/8960842 | PubMed |
| 2 | 18443195 | Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study. | Diabetes Care | 2008 | https://conductscience.org/library/papers/18443195 | PubMed |
| 3 | 17712074 | Management of diabetic retinopathy: a systematic review. | JAMA | 2007 | https://conductscience.org/library/papers/17712074 | PubMed |
| 4 | 8366922 | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8366922 | PubMed |
| 5 | 9702425 | Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. | Diabetes Care | 1998 | https://conductscience.org/library/papers/9702425 | PubMed |
| 6 | 31748169 | Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial. | Lancet Diabetes Endocrinol | 2019 | https://conductscience.org/library/papers/31748169 | PubMed |
| 7 | 2866759 | Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. | Arch Ophthalmol | 1985 | https://conductscience.org/library/papers/2866759 | PubMed |
| 8 | 15111519 | Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. | Diabetes Care | 2004 | https://conductscience.org/library/papers/15111519 | PubMed |
| 9 | 2684072 | Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? | Arch Intern Med | 1989 | https://conductscience.org/library/papers/2684072 | PubMed |
| 10 | 7732997 | Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. | Am J Cardiol | 1995 | https://conductscience.org/library/papers/7732997 | PubMed |
| 11 | 17199216 | Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy. | J Renin Angiotensin Aldosterone Syst | 2000 | https://conductscience.org/library/papers/17199216 | PubMed |
| 12 | 21309844 | Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. | Diabet Med | 2011 | https://conductscience.org/library/papers/21309844 | PubMed |
| 13 | 1778353 | UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. | Diabetologia | 1991 | https://conductscience.org/library/papers/1778353 | PubMed |
| 14 | 2062513 | Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. | Ophthalmology | 1991 | https://conductscience.org/library/papers/2062513 | PubMed |
| 15 | 9052629 | Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. | Ophthalmology | 1997 | https://conductscience.org/library/papers/9052629 | PubMed |
| 16 | 18823656 | Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. | Lancet | 2008 | https://conductscience.org/library/papers/18823656 | PubMed |
| 17 | 9538987 | Diabetic retinopathy. American Diabetes Association. | Diabetes Care | 1998 | https://conductscience.org/library/papers/9538987 | PubMed |
| 18 | 22435949 | Prevalence and risk factors for diabetic maculopathy, and its relationship to diabetic retinopathy in elderly Japanese patients with type 2 diabetes mellitus. | Geriatr Gerontol Int | 2012 | https://conductscience.org/library/papers/22435949 | PubMed |
| 19 | 11849464 | Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. | Kidney Int | 2002 | https://conductscience.org/library/papers/11849464 | PubMed |
| 20 | 15078673 | The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. | Arch Ophthalmol | 2004 | https://conductscience.org/library/papers/15078673 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42840144 | Factors associated with diabetic retinopathy: a cross-sectional study of 1477 patients across four cities in Anhui, China. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42840144 | PubMed |
| 42728351 | Incidence and baseline predictors of discontinuation in DRCRnet studies. | Eye (Lond) | 2026 | https://conductscience.org/library/papers/42728351 | PubMed |
| 42665824 | Predictors of time to diabetic retinopathy in patients with type 2 diabetes mellitus: a survival analysis study. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42665824 | PubMed |
| 42429883 | Association of rate-pressure product with diabetic retinopathy in patients with type 2 diabetes mellitus: development and internal validation of a nomogram for diabetic retinopathy identification. | Endocrine | 2026 | https://conductscience.org/library/papers/42429883 | PubMed |
| 42356165 | Foveal Density and Multi-Domain OCTA Biomarkers May Help Identify Preclinical Diabetic Microvasculopathy in Type 2 Diabetes Mellitus. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42356165 | PubMed |
| 42344825 | Diabetic Retinopathy in Bahraini Primary Care: A Cross-Sectional Study of Prevalence and Clinical Predictors. | Cureus | 2026 | https://conductscience.org/library/papers/42344825 | PubMed |
| 42227809 | Retinal Ischemic Perivascular Lesions Screen for Vision-Threatening Diabetic Retinopathy Visualized on Ultra-Widefield Fluorescein Angiography. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42227809 | PubMed |
| 42174000 | Identification and analysis of oxidative stress-related genes associated with the occurrence and development of diabetic retinopathy. | Sci Rep | 2026 | https://conductscience.org/library/papers/42174000 | PubMed |
| 42005910 | Retinal Ischemic Perivascular Lesions are Associated with Multifactorial Disease Burden and Severity of Diabetic Retinopathy. | Ophthalmol Sci | 2026 | https://conductscience.org/library/papers/42005910 | PubMed |
| 41821747 | A clinically actionable nomogram integrating HbA1c, renal function, and blood pressure for early prediction of diabetic macular edema in working-age patients with type 2 diabetes. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41821747 | PubMed |
| 41726296 | Impact of Fasting Plasma Glucose on Electrolyte Imbalance, Lipid Profile, and Associated Health Complications in Type 1 and Type 2 Diabetic Patients: A Cross-Sectional Study in Rural Bangladesh. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41726296 | PubMed |
| 41606655 | Targeting endoplasmic reticulum stress in diabetic retinopathy: mechanistic insights and emerging therapies. | Biol Res | 2026 | https://conductscience.org/library/papers/41606655 | PubMed |
| 41571723 | Clinical implications of systolic blood pressure for diabetic retinopathy across HbA1c levels in a Japanese population. | Sci Rep | 2026 | https://conductscience.org/library/papers/41571723 | PubMed |
| 41555800 | Nationwide Trends and Future Projections of Diabetes and Diabetic Retinopathy Prevalence in Korea: Korean National Health and Nutrition Examination Survey Study. | J Korean Med Sci | 2026 | https://conductscience.org/library/papers/41555800 | PubMed |
| 41414742 | Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial. | J Diabetes | 2025 | https://conductscience.org/library/papers/41414742 | PubMed |
| 41362404 | The Relationship Between Hemoglobin Levels and Proliferative Diabetic Retinopathy in Type 2 Diabetes Patients. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/41362404 | PubMed |
| 41153024 | Blood pressure variability is associated with the occurrence of diabetic microangiopathy in type 2 diabetes mellitus: a cross-sectional study. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41153024 | PubMed |
| 41019873 | Central Macular Thickness and Foveal Avascular Zone are Indicators of Early Diabetic Retinopathy. | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/41019873 | PubMed |
| 40935427 | Exploring potential target drugs for vision-threatening diabetic retinopathy using the human plasma proteome: a Mendelian randomisation study. | BMJ Open | 2025 | https://conductscience.org/library/papers/40935427 | PubMed |
| 40772141 | Metformin in Diabetic Retinopathy: Mechanisms, Therapeutic Potential, and Barriers. | Cureus | 2025 | https://conductscience.org/library/papers/40772141 | PubMed |
Drugs5
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| SIMVASTATIN | CHEMBL1064 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1064 | ChEMBL |
| OLMESARTAN MEDOXOMIL | CHEMBL1200692 | Derived from the trial | 2 | https://conductscience.org/library/drugs/CHEMBL1200692 | ChEMBL |
| AZELNIDIPINE | CHEMBL1275868 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1275868 | ChEMBL |
| AMLODIPINE | CHEMBL1491 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1491 | ChEMBL |
| FENOFIBRATE | CHEMBL672 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL672 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36975019
GET https://conductscience.org/api/papers/v1/36975019/references?page=2